Xerox Holdings Stock Declines 2.8% Since Q2 Earnings Miss

Xerox Holdings (XRX) reported a significant Q2 2025 earnings miss, posting an adjusted loss of $0.64 per share against an estimated $0.10 profit, alongside revenues of $1.58 billion that lagged expectations and declined 0.13% year-over-year. The quarter saw a 5.6% drop in equipment sales, a 170 basis point contraction in adjusted operating margin to 3.7%, and negative free cash flow of $30 million, leading to a 2.8% stock decline since the earnings release and a 59.5% year-to-date underperformance. Despite these results, Xerox provided 2025 guidance projecting 16-17% constant currency revenue growth and $250 million in free cash flow, indicating a forward-looking recovery strategy amidst current operational challenges.

Analysis

Xerox Holdings (XRX) reported a fundamentally weak second quarter for 2025, characterized by a significant miss on profitability and deteriorating operational metrics. The company posted an adjusted loss of $0.64 per share, starkly contrasting with the consensus estimate for a $0.10 profit and reversing the prior year's gains. Revenues of $1.58 billion were largely flat, declining 0.13% year-over-year and missing estimates by 0.8%. This performance was driven by a 5.6% drop in equipment sales, which overshadowed a modest 1.5% rise in post-sale revenues. Margin pressure was evident as the adjusted operating margin contracted by 170 basis points to 3.7%, and the company generated negative free cash flow of $30 million. The market reacted negatively, with the stock falling 2.8% since the announcement, compounding a 59.5% decline over the past year. In a notable disconnect from these results, management issued aggressive full-year 2025 guidance, projecting 16%-17% revenue growth and approximately $250 million in free cash flow, creating a significant execution challenge for the remainder of the year.

Key Decisions for Investors

• Investors should view the company's optimistic full-year 2025 guidance for 16-17% revenue growth with considerable skepticism, given the stark contrast with the Q2 performance, which included declining equipment sales and negative free cash flow.
• The 59.5% stock underperformance over the past year, coupled with the reported margin compression and a Zacks #4 (Sell) rating, suggests that maintaining or initiating long positions carries substantial risk until there is tangible evidence of a turnaround.
• Traders should monitor key metrics in the upcoming quarters, specifically the trajectory of equipment sales and the adjusted operating margin, as any failure to meet the aggressive guidance could trigger further downside price action.